BioPharma Credit rises 2.9% after $762m London IPO
Shares in BioPharma Credit, the UK closed end investment fund focused on the debt of life sciences companies, closed 2.9% above their IPO price on Thursday when they started trading in London on Thursday after the company finished its $762m IPO.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: